IL17A and neoplasm: However, when the cancer development reaches a chronic late stage, the pro-tumor roles of IL-17 and Th17 cells rely on their capacity to induce angiogenesis, recruit inflammatory and immunosuppressive cells and activate tumor-promoting transcription factors [25, 28–30].